Bon Natural Life Ltd

Análisis de la acción Bon Natural Life Ltd (BON)

$1.120

+0.002 (+0.20%)Al cierre

Loading chart…
Máximo
1.120
Apertura
1.092
Precio medio ponderado por volumen
1.11
Volumen
10.36K
Capitalización
9.09M
Mínimo
1.090
Importe
11.50K
EV/EBITDA, TTM
0.00

Bon Natural Life Ltd is a company principally engaged in the manufacturing and sales of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements, such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. The Company's product categories include fragrance compounds, health supplements (natural, functional active ingredients for powder drinks) and bioactive food ingredients. Fragrance compounds product category includes clary sage extract products and lavender essential oil. Bioactive food ingredients include stachyose, milk thistle extracts, apple extracts, phloretin and pomegranate extract products. The Company’s products are applied in the functional food, personal care, cosmetic and pharmaceutical industries.

www.bnlus.com

Análisis de IA of Bon Natural Life Ltd (BON)

Mantener

Bon Natural Life Ltd is currently not a strong buy due to its low RSI of 34.467, indicating oversold conditions, and a significant year-to-date change of -34.50%. While the stock has potential upside based on historical patterns projecting a +107.27% change, the current price of 1.12 is near its 52-week low of 0.95, which presents a risk if the stock does not recover. The forward P/E ratio of 2.3491 suggests potential undervaluation, but the negative sentiment and performance trends indicate caution is warranted.

Métricas de valoración

El PER previsto actual de Bon Natural Life Ltd (BON) es 2.35, frente a su media de 5 años de 4.64.

PER previsto

Valor razonable
Media 5A P/E
4.64
P/E actual
2.35
Sobrevalorada
17.92
Infravalorada
-8.64

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
1.54
EV/EBITDA actual
0.00
Sobrevalorada
3.60
Infravalorada
-0.51

Precio/ventas previsto

Valor razonable
Media 5A P/S
0.32
P/S actual
0.00
Sobrevalorada
0.66
Infravalorada
-0.02

Escenarios de precio de Alphio AI para BON

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%BON

$1.68

Precio del escenario

B

Base

Base · 50%BON

$1.48

Precio del escenario

B

Bajista

Bajista · 25%BON

$1.41

Precio del escenario

Cronología de eventos

2026-03-31 (ET)

09:10:00

Bon Natural Life Enters Cooperation Agreement with Tigerbone Group

2026-02-19 (ET)

09:10:00

Bon Natural Life Develops Apple Polyphenol Anti-Aging Mask

2025-12-10 (ET)

05:10:00

Bon Natural Life Launches New Product and Signs $12M Collaboration Agreement

2025-11-25 (ET)

09:44:21

Bon Natural Life reveals $26M partnership deal with Beijing Huahai Keyuan

2025-09-09 (ET)

08:33:15

Bon Natural Life Signs $18M Partnership Agreement in China

Noticias

Preguntas frecuentes sobre BON, respondidas por Alphio AI

Bon Natural Life Ltd is a company principally engaged in the manufacturing and sales of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements, such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. The Company's product categories include fragrance compounds, health supplements (natural, functional active ingredients for powder drinks) and bioactive food ingredients. Fragrance compounds product category includes clary sage extract products and lavender essential oil. Bioactive food ingredients include stachyose, milk thistle extracts, apple extracts, phloretin and pomegranate extract products. The Company’s products are applied in the functional food, personal care, cosmetic and pharmaceutical industries. It operates in the Healthcare sector (MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS industry).

Bon Natural Life Ltd is currently not a strong buy due to its low RSI of 34.467, indicating oversold conditions, and a significant year-to-date change of -34.50%. While the stock has potential upside based on historical patterns projecting a +107.27% change, the current price of 1.12 is near its 52-week low of 0.95, which presents a risk if the stock does not recover. The forward P/E ratio of 2.3491 suggests potential undervaluation, but the negative sentiment and performance trends indicate caution is warranted.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Artículos relacionados

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar